Oruka Therapeutics (ORKA) Assets Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.79% |
| Dec 31, 2025 | 57.49% |
| Sep 30, 2025 | 57.84% |
| Jun 30, 2025 | 98.38% |
| Mar 31, 2025 | 119.15% |
| Dec 31, 2024 | 115.42% |
| Sep 30, 2024 | 110.80% |
| Jun 30, 2024 | 26.65% |
| Mar 31, 2024 | 33.66% |
| Dec 31, 2023 | 40.87% |
| Sep 30, 2023 | 35.93% |
| Jun 30, 2023 | 32.48% |
| Mar 31, 2023 | 26.89% |
| Dec 31, 2022 | 28.36% |
| Sep 30, 2022 | 21.59% |
| Jun 30, 2022 | 22.70% |
| Mar 31, 2022 | 19.90% |
| Dec 31, 2021 | 17.40% |
| Sep 30, 2021 | 15.98% |
| Jun 30, 2021 | 14.89% |
| Mar 31, 2021 | 13.38% |
| Dec 31, 2020 | 4.97% |
| Sep 30, 2020 | 4.16% |
| Jun 30, 2020 | -23.74% |
| Mar 31, 2020 | -10.87% |
| Dec 31, 2019 | -11.95% |
| Sep 30, 2019 | -11.22% |
| Jun 30, 2019 | -12.75% |
| Mar 31, 2019 | -17.60% |
| Dec 31, 2018 | -16.77% |
| Sep 30, 2018 | -15.09% |
| Jun 30, 2018 | -13.50% |
| Mar 31, 2018 | 25.31% |
| Dec 31, 2017 | 30.94% |
| Sep 30, 2017 | 37.35% |
| Jun 30, 2017 | 35.29% |
| Mar 31, 2017 | 32.94% |
| Dec 31, 2016 | 30.52% |
| Sep 30, 2016 | 34.57% |
| Jun 30, 2016 | 30.63% |
| Dec 31, 2015 | 37.15% |